ANKRD13C: A Potential Drug Target and Biomarker (G81573)

Target Name: ANKRD13C

NCBI ID: G81573

ANKRD13C: A Potential Drug Target and Biomarker

Ankyrin repeat domains are a type of gene mutation that has been identified in a variety of organisms, including humans. These mutations are characterized by the repeated sequence of the amino acid cysteine, which is usually replaced by a cysteine-residue-containing derivative. One such gene, ANKRD13C, has been identified and is now under investigation as a potential drug target and biomarker.

The ANKRD13C gene is located on chromosome 16 and encodes a protein known as ANKRD13C. This protein is a member of the superfamily of cytoplasmic proteins known as the Ankyrin repeat proteins. These proteins are characterized by the presence of a conserved domain that consists of a series of amino acids that are similar to the cysteine residue that is present in the Ankyrin repeat domain of the protein.

One of the unique features of ANKRD13C is its structure. It has a molecular weight of 42 kDa and a pre-expression level of 2.86 mg/mL. It is also expressed in a variety of tissues, including brain, heart, liver, and muscle. Additionally, ANKRD13C has been shown to be expressed in a variety of cancer types, including breast, ovarian, and prostate cancer.

The ANKRD13C protein is involved in a variety of cellular processes, including the regulation of cell adhesion, migration, and survival. It has been shown to play a role in the development and progression of cancer, as well as in the regulation of cellular processes that are important for tissue repair and regeneration.

In addition to its potential role in cancer, ANKRD13C has also been shown to be involved in the regulation of other cellular processes that are important for normal cellular function. For example, it has been shown to play a role in the regulation of cell migration, as well as in the regulation of the cytoskeleton. Additionally, ANKRD13C has been shown to play a role in the regulation of cellular signaling pathways, including the TGF-β pathway.

Despite its potential role in a variety of cellular processes, ANKRD13C has not yet been studied as a drug target or biomarker. However, its unique structure and expression patterns, as well as its involvement in a variety of cellular processes, make it an attractive candidate for further investigation.

In conclusion, ANKRD13C is a protein that has been identified as a potential drug target and biomarker. Its unique structure and expression patterns, as well as its involvement in a variety of cellular processes, make it an attractive candidate for further investigation. Further studies are needed to determine its role in cancer and other cellular processes, as well as to develop it as a potential drug or biomarker.

Protein Name: Ankyrin Repeat Domain 13C

Functions: Acts as a molecular chaperone for G protein-coupled receptors, regulating their biogenesis and exit from the ER

More Common Targets